Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin III

Teien, 1976, Assay of heparin in plasma using a chromogenic substrate for activated factor X, Thromb. Res., 8, 413, 10.1016/0049-3848(76)90034-7 Denson, 1961, The specific assay of Prower-Stuart factor and factor VII, Acta Haematol. (Basel), 25, 105, 10.1159/000206523 Miller-Andersson, 1974, Purification of antithrombin III by affinity chromatography, Thromb. Res., 6, 439, 10.1016/0049-3848(74)90001-2 Abildgaard, 1975, Coagulation inhibitors studied with chromogenic substrate, 112 Ødegård, 1975, Heparin cofactor activity measured with an amidolytic method, Thromb. Res., 6, 287, 10.1016/0049-3848(75)90078-X Ødegård, 1976, Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex, Scand. J. Haematol., 17, 258, 10.1111/j.1600-0609.1976.tb01183.x Gjesdal, 1976, Platelet consumption and plasma concentration of platelet factor 4 (PF4), Scand. J. Haematol., 17, 5, 10.1111/j.1600-0609.1976.tb02834.x Burstein, 1951, Substances fibrinoplastiques et antifibrinoplastiques, Rev.d' Hémat., 7, 587 Yin, 1973, Plasma heparin: A unique, practical, submicrogram-sensitive assay, J. Lab. Clin. Med., 81, 298 Teien, 1975, Heparin assay in plasma: A comparison of five clotting methods, Thromb. Res., 7, 777, 10.1016/0049-3848(75)90202-9 Teien, 1976, Heparin therapy monitored by an amidolytic method, 370 GJESDAL, K. Clinical use of platelet factor 4 assay. In: Platelets and Thrombosis. Pareti, F.I. and Mills, D.C.B. (Eds.) Academic Press, London, in press. Deutsch, 1957, Uber das Vorkommen eines Antiheparinfaktors in Thrombozyten und Geweben. I. Mitteilung: Antiheparinaktivität der Thrombozyten, Thromb. Diath. Haemorrh., 1, 397 Godal, 1962, The antiheparin effect of platelets, Scand. J. Clin. Lab. Invest., 14, 223, 10.3109/00365516209079698 TEIEN, A.N., ABILDGAARD, U., HOOK, M. and LINDAHL, U. Anticoagulant effect of human and animal heparins studied with amidolytic methods. In preparation.